Press Releases

Michigan Revises Prior Authorization Criteria for Endari®

Dec 10, 2020 11:30am EST

Emmaus Life Sciences Launches Endari® Support Program

Dec 08, 2020 11:30am EST

Endari® Granted Orphan Drug Status in Switzerland

Dec 03, 2020 11:20am EST

Emmaus Life Sciences Submits Temporary License Application in Bahrain for Endari®

Nov 10, 2020 11:25am EST

FDA Approves Updated Label for Endari®

Nov 03, 2020 11:30am EST

Emmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc. Shares

Oct 14, 2020 11:20am EDT

Emmaus Life Sciences Announces Informational Stockholders Meeting

Sep 01, 2020 8:00am EDT

UPDATE - Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority

Aug 18, 2020 1:41pm EDT

Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority

Aug 18, 2020 8:00am EDT

Emmaus Life Sciences Reports Additional Positive Preliminary Results in Diverticulosis Pilot Trial

Aug 05, 2020 8:00am EDT